drugset / Trial / NCT04386057
LY3214996 +/- HCQ in Pancreatic Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is evaluating the safety and efficacy of combining the study drug LY3214996 with hydroxychloroquine sulfate (HCQ) in patients with advanced pancreatic cancer.
Timeline
- Start
- 2020-05-27
- Primary completion
- 2023-08-09
- Completion
- 2024-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | — | Oral |
| Subject | TEMUTERKIB | Small molecule | — | Oral |